Abstract
Obesity is now a well-established promoter of cancer progression and decreased overall patient survival. Ever since the association between obesity and cancer was appreciated, adipose tissue, adipocytes, and secreted fat-derived factors have been a focus of the mechanism underlying this link. Adipose-secreted factors cytokines are referred to as adipocytokines and represent the group of molecules thought to link adipose or fat cells to initiation and promotion of various cancers. There are over 20 identified adipokines, of which, a subset has been implicated in cancer. In this chapter, we will provide a concise review of the current literature on the subset of adipose-derived factors linked to cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sethi JK, Vidal-Puig AJ (2007) Thematic review series: adipocyte biology.Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 48:1253–1262
Diedrich J, Gusky HC, Podgorski I (2015) Adipose tissue dysfunction and its effects on tumor metabolism. Horm Mol Biol Clin Investig 21(1):17–41
Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM (2009) Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr 19:109–124
Ogden CL, Carroll M, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311(8):806–814
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638
Jones DH, Nestore M, Henophy S, Cousin J, Comtois AS (2014) Increased cardiovascular risk factors in breast cancer survivors identified by routine measurements of body composition, resting heart rate and arterial blood pressure. Springerplus 3:150
Wolin KY, Carson K, Colditz GA (2010) Obesity and cancer. Oncologist 15:556–565
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: a cohort study. Br Med J 355:1314
Booth A, Magnuson A, Fouts J, Foster M (2015) Adipose tissue, obesity, and adipokines: role in cancer promotion. Horm Mol Biol Clin Investig 21(1):57–74
Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91
Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93(11 Suppl 1):S64–S73
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425–432
Muoio DM, Dohm G, Tapscott EB, Coleman RA (1999) Leptin opposes insulin’s effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am J Physiol 276(5 Pt 1):E913–E921
Gibson TM, Park Y, Robien K, Shiels MS, Black A, Sampson JN, Purdue MP, Beane Freeman LE, Andreotti G, Weinstein SJ, Albanes D, Fraumeni JF Jr, Curtis RE, Berrington de Gonzalez A, Morton LM (2014) Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies. J Clin Oncol 32:4004–4011
Bhaskaran K, Douglas I, Forbes H, dos-Santos Silva I, Leon DA, Smeeth L (2014) Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384:755–765
Garcia-Robles MJ, Segura-Ortega J, Fafutis-Morris M (2013) The biology of leptin and its implications in breast cancer: a general view. J Interferon Cytokine Res 33:717–727
Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim SY, Hamnvik OP, Koniaris A (2011) Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 301:E567–E584
Jarde T, Perrier S, Vasson MP, Caldefie-Chezet F (2011) Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 47:33–43
Vona-Davis L, Rose D (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14:189–206
Zheng Q, Dunlap S, Zhu J, Downs-Kelly E, Rich J, Hursting SD, Berger NA, Reizes O (2011) Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr Relat Cancer 18(4):491–503
Zheng Q, Banaszak L, Fracci S, Basali D, Dunlap SM, Hursting SD, Rich JN, Hilemeland AB, Vasanji A, Berger NA, Lathia JD, Reizes O (2013) Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Endocr Relat Cancer 20:797–808
Tewari R, Rajender S, Natu SM, Goel A, Dalela D, Goel MM, Tondon P (2013) Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men—a cross-sectional study. Cytokine 63:130–134
Bain GH, Collie-Duguid E, Murray GI, Gilbert FJ, Denison A, McKiddie F, Ahearn T, Fleming I, Leeds J, Phull P, Park K, Nanthakumaran S, Grabsch HI, Tan P, Welch A, Schweiger L, Dahle-Smith A, Urquhart G, Finegan M, Petty RD (2014) Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas. Br J Cancer 110:1525–1534
Dong Z, Fu S, Xu X, Yang Y, Du L, Li W, Kan S, Li Z, Zhang X, Wang L, Li J, Liu H, Qu X, Wang C (2014) Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration. Br J Cancer 110:1801–1810
Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S (2007) Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol 60(8):902–906
Yehuda-Shnaidman E, Nimri L, Tarnovscki T, Kirshtein B, Rudich A, Schwartz B (2013) Secreted human adipose leptin decreases mitochondrial respiration in HCT116 colon cancer cells. PLoS One 8, e74843
Xiong Y, Zhang J, Liu M, An M, Lei L, Guo W (2014) Human leptin protein activates the growth of HepG2 cells by inhibiting PERK mediated ER stress and apoptosis. Mol Med Rep 10:1649–1655
Kadowaki T, Yamauchi T (2015) Adiponectin and adiponectin receptors. Endocr Rev 26:439–451
Yamauchi N, Takazawa Y, Maeda D, Hibiya T, Tanaka M, Iwabu M, Okada-Iwabu M, Yamauchi T, Kadowaki T, Fukayama M (2012) Expression levels of adiponectin receptors are decreased in human endometrial adenocarcinoma tissues. Int J Gynecol Pathol 31:352–357
Grossmann ME, Nkhata K, Mizuno NK, Ray A, Cleary MP (2008) Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98:370–379
Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345:271–279
Wang Y, Lam K, Xu JY, Lu G, Xu LY, Cooper GJ, Xu A (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280:18341–18347
Goktas S, Yilmaz M, Caglar K, Sonmez A, Kilic S, Bedir S (2005) Prostate cancer and adiponectin. Urology 65:1168–1172
Bub JD, Miyazaki T, Iwamoto Y (2006) Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun 340:1158–1166
Alexandre L, Long E, Beales IL (2014) Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol 5:534–549
Otani K, Kitayama J, Kamei T, Soma D, Miyato H, Yamauchi T, Kadowaki T, Nagawa H (2010) Adiponectin receptors are downregulated in human gastric cancer. J Gastroenterol 45:918–927
Nakajima TE, Yamada Y, Hamano T, Furuta K, Matsuda T, Fujita S, Kato K, Hamaguchi T, Shimada Y (2010) Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 101:1286–1291
Moon HS, Chamberland JP, Aronis K, Tseleni-Balafouta S, Mantzoros CS (2011) Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans. Mol Cancer Ther 10:2234–2243
Erdogan S, Sezer S, Baser E, Gun-Eryilmaz O, Gungor T, Uysal S, Yilmaz FM (2013) Evaluating vaspin and adiponectin in postmenopausal women with endometrial cancer. Endocr Relat Cancer 20:669–675
Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14:1431–1437
Preiss J, Handler P (1957) Enzymatic synthesis of nicotinamide mononucleotide. J Biol Chem 225:759–770
Rongvaux A, Shea R, Mulks MH, Gigot D, Urbain J, Leo O, Andris F (2002) Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 32:3225–3234
Chen MP, Chung F, Chang DM, Tsai JCR, Huang HF, Shin SJ, Lee YJ (2006) Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91:295–299
Andrade-Oliveira V, Camara NO, Moraes-Vieira PM (2015) Adipokines as drug targets in diabetes and underlying disturbances. J Diabetes Res 2015:681612
Yun MR, Seo J, Park HY (2014) Visfatin contributes to the differentiation of monocytes into macrophages through the differential regulation of inflammatory cytokines in THP-1 cells. Cell Signal 26(4):705–715
Huang WS, Chen C, Sze CI, Teng CC (2013) Visfatin induces stromal cell-derived factor-1 expression by beta1 integrin signaling in colorectal cancer cells. J Cell Physiol 228:1017–1024
Bułdak RJ, Buldak L, Polaniak R, Kukla M, Birkner E, Kubina R, Kabała-Dzik A, Duława-Bułdak A, Żwirska-Korczala K (2013) Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study. Oncol Rep 29:771–778
Shackelford RE, Bui M, Coppola D, Hakam A (2010) Over-expression of nicotinamide phosphoribosyltransferase in ovarian cancers. Int J Clin Exp Pathol 3:522–527
Lehrke M, Reilly M, Millington SC, Iqbal N, Rader DJ, Lazar MA (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1:161–168
Silswal N, Singh A, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ (2005) Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 334:1092–1101
Verma S, Li S, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA (2003) Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108:736–740
Yadav A, Kumar B, Datta J, Teknos TN, Kumar P (2011) IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 9:1658–1667
Hsieh YY, Shen C, Huang WS, Chin CC, Kuo YH, Hsieh MC, Yu HR, Chang TS, Lin TH, Chiu YW, Chen CN, Kuo HC, Tung SY (2014) Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFkB signaling pathway in gastric cancer cells. J Biomed Sci 21:59
Yang CC, Chang S, Chao JK, Lai YL, Chang WE, Hsu WH, Kuo WH (2014) Activation of AMP-activated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin. BMC Cancer 14:112
Carpene C, Dray C, Attane C, Valet P, Portillo MP, Churruca I, Milagro FI, Castan-Laurell I (2007) Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 63:359–373
Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpéné C, Audigier Y, Saulnier-Blache JS, Valet P (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146:1764–1771
Castan-Laurell I, Dray C, Attane C, Duparc T, Knauf C, Valet P (2011) Apelin, diabetes, and obesity. Endocrine 40:1–9
Yoshiya S, Shirabe K, Imai D, Toshima T, Yamashita Y, Ikegami T, Okano S, Yoshizumi T, Kawanaka H, Maehara Y (2015) Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy. J Gastroenterol 50:573–582
Altinkaya SO, Nergiz S, Küçük M, Yüksel H (2015) Apelin levels are higher in obese patients with endometrial cancer. J Obstet Gynaecol Res 41:294–300
Berta J, Hoda M, Laszlo V, Rozsas A, Garay T, Torok S, Grusch M, Berger W, Paku S, Renyi-Vamos F, Masri B, Tovari J, Groger M, Klepetko W, Hegedus B, Dome B (2014) Apelin promotes lymphangiogenesis and lymph node metastasis. Oncotarget 5:4426–4437
Goralski KB, McCarthy T, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S, Sinal CJ (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 282:28175–28188
Wittamer V, Franssen J, Vulcano M, Mirjolet JF, Le Poul E, Miggeotte I, Brezillion S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M, Communi D (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 198:977–985
Rama D, Esendagli G, Guc D (2011) Expression of chemokine-like receptor 1 (CMKLR1) on J744A.1 macrophages co-cultured with fibroblast and/or tumor cells: modeling the influence of microenvironment. Cell Immunol 271:134–140
Wang C, Wu W, Liu X, To KF, Chen GG, Yu J, Ng EK (2014) Increased serum chemerin level promotes cellular invasiveness in gastric cancer: a clinical and experimental study. Peptides 51:131–138
Zhang J, Jin H, Zhu AK, Ying RC, Wei W, Zhang FJ (2014) Prognostic significance of plasma chemerin levels in patients with gastric cancer. Peptides 61:7–11
Tsuji S, Uehori J, Matsumoto M, Suzuki Y, Matsuhisa A, Toyoshima K, Seya T (2001) Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem 276:23456–23463
Yang RZ, Lee M, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290:E1253–E1261
Ohashi K, Shibata R, Murohara T, Ouchi N (2014) Role of anti-inflammatory adipokines in obesity-related diseases. Trends Endocrinol Metab 25:348–355
Smitka K, Marešová D (2015) Adipose tissue as an endocrine organ: an update on proinflammatory and anti-inflammatory microenvironment. Prague Med Rep 116(2):87–111
Uyeturk U, Sarıcı H, Kın Tekce B, Eroglu M, Kemahlı E, Uyeturk U, Gucuk A (2014) Serum omentin level in patients with prostate cancer. Med Oncol 31:923
Uyeturk U, Alcelik A, Aktas G, Tekce BK (2014) Post-treatment plasma omentin levels in patients with stage III colon carcinoma. J BUON 19:681–685
Zhang YY, Zhou L (2013) Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. Eur J Pharmacol 698:137–144
Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, Kern W, Hillhouse EW, Lehnert H, Tan BK, Randeva HS (2010) Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 151:3169–3180
Yang M, Zhang Z, Wang C, Li K, Li S, Boden G, Li L, Yang G (2012) Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance. Diabetes 61:1959–1968
Xu Y, Pang X, Dong M, Wen F, Zhang Y (2013) Nesfatin-1 inhibits ovarian epithelial carcinoma cell proliferation in vitro. Biochem Biophys Res Commun 440:467–472
Wada J (2008) Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 17:327–333
Blüher M (2012) Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 41:176–182
Noy N, Li L, Abola MV, Berger NA (2015) Is retinol binding protein 4 a link between adiposity and cancer? Horm Mol Biol Clin Investig 23:39–46
Nieman KM, Romero IL, Van Houten B, Lengyel E (2013) Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 1831:1533–1541
Nieman KM, Kenny H, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, Lengyel E (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17:1498–1503
Liu Y (2006) Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer Prostatic Dis 9:230–234
Baron A, Migita T, Tang D, Loda M (2004) Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 91:47–53
Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I (2014) Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases. Cancer Metastasis Rev 33:527–543
Conflict of Interest
None to declare.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Saygin, C., Reizes, O., Berger, N.A. (2017). Adipocytes, Adipocytokines, and Cancer. In: Reizes, O., Berger, N. (eds) Adipocytokines, Energy Balance, and Cancer. Energy Balance and Cancer, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-319-41677-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-41677-9_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41675-5
Online ISBN: 978-3-319-41677-9
eBook Packages: MedicineMedicine (R0)